Target intelligence / Profile preview

Cancer-associated biomarkers

Molecular classification
Proteins, Nucleic acids, Lipids, Metabolites, Exosomes
01

Overview

Cancer-associated biomarkers are biological molecules or characteristics found in blood, tissues, or other body fluids that indicate the presence of cancer or provide information about its behavior (National Cancer Institute: https://www.cancer.gov/publications/dictionaries/cancer-terms/def/biomarker). These markers include a diverse array of molecules such as proteins, DNA mutations, RNA expression patterns, and metabolites (NIH BEST Resource: https://www.ncbi.nlm.nih.gov/books/NBK338448/). They are essential tools in modern oncology for screening, diagnosing specific cancer types, and determining the prognosis of a patient (Nature Reviews Cancer: https://www.nature.com/articles/nrc.2017.74). Furthermore, predictive biomarkers are used to identify patients most likely to benefit from specific targeted therapies, such as using HER2 status to guide the use of trastuzumab (American Cancer Society: https://www.cancer.org/cancer/diagnosis-staging/tests/biomarker-tests.html). While some biomarkers are also therapeutic targets, the category as a whole represents the measurable indicators of disease state rather than a single receptor or enzyme. The clinical application of these biomarkers facilitates precision medicine by tailoring treatments to the molecular profile of an individual's tumor (PubMed: 30089180). However, the use of biomarkers is often complicated by issues of sensitivity and specificity, which can lead to false positive or false negative results (StatPearls: https://www.ncbi.nlm.nih.gov/books/NBK559036/). Monitoring changes in biomarker levels over time also allows clinicians to assess treatment efficacy and detect early signs of recurrence (Journal of Clinical Oncology: https://ascopubs.org/journal/jco).

Other names
Tumor markersOncology biomarkersCancer markersClinical biomarkers
02

Mechanism of action

Mechanisms of action are specific to the individual biomarker being targeted; they include inhibition of receptor tyrosine kinases, blockade of immune checkpoints, and modulation of hormone receptors (PubMed: 28930210).

03

Biological functions

Signal transductionCell cycle regulationApoptosisDNA repairImmune evasion
04

Disease associations

Cancer
05

Safety considerations

False positive results leading to unnecessary invasive proceduresFalse negative results leading to delayed diagnosisOverdiagnosis of slow-growing tumorsPotential for psychological distress in patientsHigh cost and limited accessibility of advanced molecular testing
06

Interacting drugs

4 more in the full profile.

07

Biomarkers

Carcinoembryonic antigen (CEA)Prostate-specific antigen (PSA)HER2/neuProgrammed death-ligand 1 (PD-L1)CA-125BCR-ABL fusion protein

Beyond the preview

Go deeper on Cancer-associated biomarkers.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cancer-associated biomarkers.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call